Assessing the Effectiveness of Health Interventions for Cost-effectiveness Analysis. Panel on Cost-Effectiveness in Health and Medicine

Overview

Journal J Gen Intern Med

Publisher Springer

Specialty General Medicine

Date 1997 Sep 19

PMID 9294789

Citations 18

Authors

J S Mandelblatt

D G Fryback

M C Weinstein

L B Russell

M R Gold

Affiliations

Soon will be listed here.

Citing Articles

Bibliometric study on scientific productivity in the use of smart bracelets.

Sulla-Torres J, Vidal-Espinoza R, Avendano Llanque C, Calla Gamboa A, Zuniga Carnero M, Cossio-Bolanos M Eur J Transl Myol. 2023; 33(4).

PMID: 37817637 PMC: 10811634. DOI: 10.4081/ejtm.2023.11572.

Restructuring lung cancer care to accelerate diagnosis and treatment in patients vulnerable to healthcare disparities using an innovative care model.

Copeland J, Neal E, Phillips W, Hofferberth S, Lathan C, Donington J MethodsX. 2023; 11:102338.

PMID: 37701734 PMC: 10494257. DOI: 10.1016/j.mex.2023.102338.

Costs and models used in the economic analysis of Total Knee Replacement (TKR): A systematic review.

Gandhi N, Qadeer A, Meher A, Rachel J, Patra A, John J PLoS One. 2023; 18(7):e0280371.

PMID: 37490490 PMC: 10368258. DOI: 10.1371/journal.pone.0280371.

The Integration of Clinical Decision Support Systems Into Telemedicine for Patients With Multimorbidity in Primary Care Settings: Scoping Review.

Wiwatkunupakarn N, Aramrat C, Pliannuom S, Buawangpong N, Pinyopornpanish K, Nantsupawat N J Med Internet Res. 2023; 25:e45944.

PMID: 37379066 PMC: 10365574. DOI: 10.2196/45944.

Cost-effectiveness of the combination of immunotherapy and chemotherapy for extensive-stage small-cell lung cancer: a systematic review.

Wang T, Li Y, Zheng X BMC Health Serv Res. 2023; 23(1):691.

PMID: 37365540 PMC: 10294391. DOI: 10.1186/s12913-023-09727-7.

References

Fryback D . Bayes' theorem and conditional nonindependence of data in medical diagnosis. Comput Biomed Res. 1978; 11(5):423-34. DOI: 10.1016/0010-4809(78)90001-0. View

Dickersin K, Berlin J . Meta-analysis: state-of-the-science. Epidemiol Rev. 1992; 14:154-76. DOI: 10.1093/oxfordjournals.epirev.a036084. View

Prorok P, Hankey B, Bundy B . Concepts and problems in the evaluation of screening programs. J Chronic Dis. 1981; 34(4):159-71. DOI: 10.1016/0021-9681(81)90026-6. View

MORRISON A . Case definition in case-control studies of the efficacy of screening. Am J Epidemiol. 1982; 115(1):6-8. DOI: 10.1093/oxfordjournals.aje.a113280. View

Black W, Welch H . Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med. 1993; 328(17):1237-43. DOI: 10.1056/NEJM199304293281706. View

BROWN B, Brauner C, Minnotte M . Noncancer deaths in white adult cancer patients. J Natl Cancer Inst. 1993; 85(12):979-87. DOI: 10.1093/jnci/85.12.979. View

. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993; 269(23):3015-23. View

Beck J, Pauker S, Gottlieb J, Klein K, Kassirer J . A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making. Am J Med. 1982; 73(6):889-97. DOI: 10.1016/0002-9343(82)90787-2. View

Shwartz M . Validation and use of a mathematical model to estimate the benefits of screening younger women for breast cancer. Cancer Detect Prev. 1981; 4(1-4):595-601. View

10.

Riddiough M, Sisk J, Bell J . Influenza vaccination. JAMA. 1983; 249(23):3189-95. View

11.

Begg C, Greenes R . Assessment of diagnostic tests when disease verification is subject to selection bias. Biometrics. 1983; 39(1):207-15. View

12.

Weiss N . Control definition in case-control studies of the efficacy of screening and diagnostic testing. Am J Epidemiol. 1983; 118(4):457-60. DOI: 10.1093/oxfordjournals.aje.a113650. View

13.

Beck J, Pauker S . The Markov process in medical prognosis. Med Decis Making. 1983; 3(4):419-458. DOI: 10.1177/0272989X8300300403. View

14.

Habbema J, Van Oortmarssen G, Lubbe J, van der Maas P . The MISCAN simulation program for the evaluation of screening for disease. Comput Methods Programs Biomed. 1985; 20(1):79-93. DOI: 10.1016/0169-2607(85)90048-3. View

15.

Park R, Fink A, Brook R, Chassin M, Kahn K, Merrick N . Physician ratings of appropriate indications for six medical and surgical procedures. Am J Public Health. 1986; 76(7):766-72. PMC: 1646864. DOI: 10.2105/ajph.76.7.766. View

16.

Sacks H, Berrier J, Reitman D, CHALMERS T . Meta-analyses of randomized controlled trials. N Engl J Med. 1987; 316(8):450-5. DOI: 10.1056/NEJM198702193160806. View

17.

Labbe K, Detsky A, ORourke K . Meta-analysis in clinical research. Ann Intern Med. 1987; 107(2):224-33. DOI: 10.7326/0003-4819-107-2-224. View

18.

Eddy D . The frequency of cervical cancer screening. Comparison of a mathematical model with empirical data. Cancer. 1987; 60(5):1117-22. DOI: 10.1002/1097-0142(19870901)60:5<1117::aid-cncr2820600533>3.0.co;2-h. View

19.

Weinstein M, Coxson P, Williams L, Pass T, Stason W, Goldman L . Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model. Am J Public Health. 1987; 77(11):1417-26. PMC: 1647098. DOI: 10.2105/ajph.77.11.1417. View

20.

Oster G, Epstein A . Cost-effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease. The case of cholestyramine. JAMA. 1987; 258(17):2381-7. View